Taylor & Adler (2020) defined that the diagnosis of Danon disease is usually established in a female proband with cardiac preexcitation and cardiomyopathy (either hypertrophic or dilated) by identification of a heterozygous pathogenic mutation in LAMP2 on molecular genetic testing. Here, LAMP2 is linked to cardiomyopathy.